ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JENNIFER BAKER APRN

VANDERBILT MEDICAL CTR 6000 MEDICAL CENTER EAST

Nashville | Tennessee | 37232

(615) 776-8930

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Nurse Practitioner, Gerontology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,419Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 11

$483K Total Retail Price of All Prescriptions

Rank: 2 out of 11

197 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 197 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

25% of this provider’s 197 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 8,996 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 404 392 1 2
HYDROCODONE-ACETAMINOPHEN 403 389 S3 2 1
SIMVASTATIN 324 310 3 5
OMEPRAZOLE 296 280 4 4
FUROSEMIDE 284 261 5 3
METOPROLOL TARTRATE 253 249 6 12
LISINOPRIL 237 237 7 7
MIRTAZAPINE 215 215 8 14
POLYETHYLENE GLYCOL 3350 214 200 9 11
AMLODIPINE BESYLATE 200 200 10 9
JANTOVEN 195 195 11 13
DONEPEZIL HCL 195 195 11 17
CYMBALTA 187 187 13 8
TRAZODONE HCL 173 161 14 19
GABAPENTIN 159 154 15 6
LACTULOSE 159 133 15 10
LANTUS 131 131 17 27
ATORVASTATIN CALCIUM 125 125 18 46
NAMENDA 119 119 19 29
ESCITALOPRAM OXALATE 119 111 19 24
CITALOPRAM HBR 107 107 21 18
OXYBUTYNIN CHLORIDE ER 100 100 22 36
ALENDRONATE SODIUM 99 86 23 38
TAMSULOSIN HCL 97 97 24 33
CARVEDILOL 97 85 24 26
LIDODERM 90 90 26 59
FENTANYL 89 84 S2 27 15
POTASSIUM CHLORIDE 88 88 28 16
HYDROCHLOROTHIAZIDE 86 86 29 42
NYSTATIN 85 84 30 22
ALBUTEROL SULFATE 84 83 31 30
DIVALPROEX SODIUM 83 83 32 44
SERTRALINE HCL 83 83 32 31
METOPROLOL SUCCINATE 82 70 34 36
CARBIDOPA-LEVODOPA 76 76 35 23
QUETIAPINE FUMARATE 75 75 36 45
OLANZAPINE 70 70 37 32
RANITIDINE HCL 69 69 38 25
CALCITONIN-SALMON 68 68 39 64
IPRATROPIUM BROMIDE 67 66 40 35
VESICARE 62 50 41 68
ADVAIR DISKUS 59 59 42 73
NOVOLIN R 59 58 42 73
KLOR-CON M20 58 54 44 76
HUMULIN R 55 55 45 79
DILTIAZEM 24HR ER 54 54 46 80
GLIMEPIRIDE 53 53 47 39
ABILIFY 53 53 47 84
LATANOPROST 53 53 47 84
CLOPIDOGREL 53 53 47 84
NITROFURANTOIN 53 51 47 84
EXELON 52 52 52 55
HYDRALAZINE HCL 51 39 53 91
DIOVAN 51 51 53 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.